[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@OzmosiHealth Ozmosi
Ozmosi posts on X about more info, targets, $bmy, $xbi the most. They currently have XXXXX followers and 2301 posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX +11%
- X Month XXXXXXX -XXXX%
- X Months XXXXXXX -XXXX%
- X Year XXXXXXXXX +54%
Mentions: XXX #
- X Week XXX -XX%
- X Month XXX -XX%
- X Months XXXXX -XX%
- X Year XXXXX +28%
Followers: XXXXX #
- X Week XXXXX +0.95%
- X Month XXXXX +2.10%
- X Months XXXXX +26%
- X Year XXXXX +38%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks XXXX% cryptocurrencies XXXX% countries XXXX% finance XXXX% technology brands XXXX%
Social topic influence more info #127, targets #429, $bmy #11, $xbi #23, $nbix #9, $ibb #5, $xph #2, $pph #1, bmy 0.17%, $cytk #2
Top accounts mentioned or mentioned by @lookingatthis2 @paulmarganski @towiu2 @christo68098001 @salmanfirat2 @john06746191 @stewdomer @dwill3000 @chrismangum14 @nicolem52807658
Top assets mentioned Bristol-Myers Squibb Co (BMY) Bitcoin Incognito (XBI) Neurocrine Biosciences, Inc. (NBIX) Cytokinetics Inc. (CYTK) Gilead Sciences, Inc. (GILD) LYRA (LYRA) Merus N.V. Common Shares (MRUS) Nuvalent, Inc. Class A Common Stock (NUVL) Mineralys Therapeutics, Inc. Common Stock (MLYS) Gud Tech (GUD) Corcept Therapeutics Inc. (CORT) Sarepta Therapeutics, Inc. (SRPT) Dyne Therapeutics, Inc. Common Stock (DYN) Viatris Inc (VTRS) AB (prev. Newton) (AB) Pfizer, Inc. (PFE) Amgen, Inc. (AMGN) Agios Pharmaceuticals, Inc. (AGIO) Denali Therapeutics Inc. Common Stock (DNLI) Eli Lilly and Company (LLY) Krystal Biotech, Inc. Common Stock (KRYS) Acadia Pharmaceuticals Inc. (ACAD) BOLT Token (BOLT) Synthetify (SNY) Nano (XNO) BioMarin Pharmaceutical, Inc. (BMRN) Alnylam Pharmaceuticals, Inc. (ALNY) AbbVie Inc (ABBV)
Top Social Posts #
Top posts by engagements in the last XX hours
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $NBIX Neurocrine will present Phase X Depressive Disorder Major Data for Osavampator (AMPA Modulator - Small Molecule) tomorrow 👀"
X Link @OzmosiHealth 2025-09-18T11:12Z 2769 followers, XXX engagements
"$GILD Gilead Sciences announced they will present Phase X Triple Negative Breast Cancer results on 2025-10-19 for Sacituzumab govitecan More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"$BMY Bristol-Myers Squibb announced they will present Phase X Ovarian Cancer results on 2025-10-19 for Izalontamab brengitecan More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2769 followers, XX engagements
"$LYRA +4.48% today as Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase X ENLIGHTEN X Study More Info:"
X Link @OzmosiHealth 2025-10-06T13:47Z 2770 followers, XXX engagements
"$MSCLF Satellos Bioscience presented Phase X Muscular Dystrophy Duchenne results on 2025-10-10 for SAT-3247 More Info:"
X Link @OzmosiHealth 2025-10-13T20:27Z 2769 followers, XXX engagements
"$IPH as Innate Pharma to Host Analyst and Investor Event on Lacutamab on October XX 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2768 followers, XX engagements
"$MRUS +0.53% today as Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2769 followers, XXX engagements
"$SRPT Sarepta announced they will present Phase X Muscular DystrophiesMuscular Dystrophy Duchenne results on 2025-10-11 for Delandistrogene moxeparvovec More Info:"
X Link @OzmosiHealth 2025-10-06T20:04Z 2770 followers, 1562 engagements
"$SLS +6.30% today as SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2768 followers, XXX engagements
"$CYTK Cytokinetics presented Phase X Cardiomyopathy Hypertrophic results on 2025-09-29 for Aficamten More Info:"
X Link @OzmosiHealth 2025-10-01T00:00Z 2769 followers, XXX engagements
"$DYN Dyne Therapeutics gets FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy. More Info: $XBI $IBB $XPH $PPH"
X Link @OzmosiHealth 2025-08-04T11:32Z 2770 followers, XXX engagements
"$IMNN +2.61% today as IMUNON to Present Phase X Ovarian Cancer Study of IMNN-001 at ESMO Congress More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$NUVL +1.86% today as Nuvalent to Present New Preclinical Data for HER2-Selective Inhibitor NVL-330 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2769 followers, XXX engagements
"$CGEN Compugen announced they will present Phase X Ovarian Cancer results on 2025-10-18 for COM-701 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XX engagements
"Intercept Pharma pulls Ocaliva from US market due to serious liver issues deaths in PBC patients. Nine-year run plagued by warnings limited use failed expansion. New treatments reshaping PBC market. Gileads Livdelzi Ipsens Iqirvo and Zydus saroglitazar on the rise. #healthcare #pharma"
X Link @OzmosiHealth 2025-09-12T15:14Z 2769 followers, XXX engagements
"$EVAX +2.74% today as Evaxion to present a breadth of data from phase X trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2770 followers, XXX engagements
"$VTRS +1.67% today as Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection More Info:"
X Link @OzmosiHealth 2025-09-17T14:07Z 2771 followers, XXX engagements
"$BMY +3.43% today as Bristol Myers Squibb's Anti-MTBR-Tau-Targeting Antibody BMS-986446 Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer's Disease More Info:"
X Link @OzmosiHealth 2025-10-01T13:42Z 2769 followers, XXX engagements
"Sanofis partnered 212Pb-DOTAMTATE (AlphaMedix) achieved all key efficacy endpoints in a mid-stage trial of the alpha radioligand therapy"
X Link @OzmosiHealth 2025-10-08T14:35Z 2770 followers, XXX engagements
"$REGMY as 2025 ACR Abstract Released Exciting Data from Telitacicept's Phase III Clinical Study in Sjgren's Syndrome in China More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XX engagements
"$PGEN +0.16% today as Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2770 followers, XXX engagements
"$CDTX -XXXX% today as Cidara Therapeutics to Present Late-Breaking Clinical Phase X Data on CD388 at ID Week 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2768 followers, XXX engagements
"$GNPX +14.90% today as Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$MCRB +0.49% today as Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025 Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XX engagements
"$RPTX Repare Therapeutics announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-25 for RP-1664 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"Excellergy launches with $70M Series A funding to advance its pipeline focused on effector cell response therapies"
X Link @OzmosiHealth 2025-10-13T13:26Z 2770 followers, XXX engagements
"$BMY Bristol-Myers Squibb announced they will present Phase X Nasopharyngeal Cancer results on 2025-10-19 for Izalontamab brengitecan More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2769 followers, XXX engagements
"$NBIX -XXXX% today as Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden More Info:"
X Link @OzmosiHealth 2025-09-23T13:45Z 2769 followers, XXX engagements
"$CDTX Cidara announced they will present Phase X Influenza Human results on 2025-10-20 for CD-388 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"$GMAB -XXXX% today as Genmab Announces Net Sales of DARZALEX (daratumumab) for Third Quarter of 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$NCNA -XXXX% today as NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$BMY Bristol-Myers Squibb announced they will present Phase X Colorectal Cancer results on 2025-10-20 for Nivolumab More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2769 followers, XX engagements
"$AB +0.81% today as AB Science will hold a virtual conference on Thursday October XX 2025 from 2pm to 3pm CET to provide an update on the Phase X study with AB8939 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2768 followers, XX engagements
"$PFE +0.04% today as TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$BRCTF as Leqembi Iqlik (lecanemab-irmb) selected by TIME as one of the best innovations of 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$ZLAB Zai Lab announced they will present Phase X Small Cell Lung Cancer results on 2025-10-24 for Zocilurtatug pelitecan More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2770 followers, XXX engagements
"$PALI -XXXXX% today as Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2769 followers, XXX engagements
"$MLYS +1.07% today as Mineralys Therapeutics Completes Enrollment in Phase X EXPLORE-OSA Trial of Lorundrostat in Obstructive Sleep Apnea and Hypertension More Info:"
X Link @OzmosiHealth 2025-09-30T13:40Z 2769 followers, XXX engagements
"$CYTK PDUFA Summary: Cytokinetics misled investors about FDA approval timeline for Aficamten leading to stock price inflation and losses. More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2770 followers, XXX engagements
"$MSCL as Satellos Announces New Data Further Demonstrating Safety Tolerability and Functional Impact of SAT-3247 in First-in-Human Trial of Adults with Duchenne Muscular Dystrophy More Info:"
X Link @OzmosiHealth 2025-10-10T14:07Z 2771 followers, XXX engagements
"$CGEN +12.61% today as Compugen to Present Pooled Analysis of COM701 in Three Phase X Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2769 followers, XXX engagements
"$ZNTL -XXXX% today as Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2770 followers, XXX engagements
"$AMGN -XXXX% today as AMGEN MAKES REPATHA AVAILABLE THROUGH AMGENNOW A DIRECT-TO-PATIENT PROGRAM IN THE U.S. More Info:"
X Link @OzmosiHealth 2025-10-06T13:47Z 2771 followers, XXX engagements
"$CADL -XXXX% today as Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$ASMB Assembly Biosciences presented Phase X Sexually Transmitted DiseasesHerpes Simplex results on 2025-10-10 for ABI-5366 More Info:"
X Link @OzmosiHealth 2025-10-13T20:27Z 2769 followers, XXX engagements
"$NBIX Neurocrine presented Phase X Huntington Disease results on 2025-10-06 for Valbenazine More Info:"
X Link @OzmosiHealth 2025-10-08T01:56Z 2769 followers, XXX engagements
"$GILD Gilead Sciences announced they will present Phase X Esophageal CancerGastrointestinal Cancer results on 2025-10-18 for Zimberelimab More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XX engagements
"$PALI -XXXX% today as Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108 More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2769 followers, XXX engagements
"$AGIO FDA extended PDUFA goal date for Agios Pharmaceuticals' drug Pyrukynd by X months to December X 2025. More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"$DNLI -XXXX% today as Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome) More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2769 followers, XXX engagements
"$TSHA +39.18% today as Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome More Info:"
X Link @OzmosiHealth 2025-10-02T13:59Z 2769 followers, XXX engagements
"$LLY -XXXX% today as Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2769 followers, XXX engagements
"$GUD as Knight Therapeutics Announces Relaunch of MYFEMBREE in Canada More Info:"
X Link @OzmosiHealth 2025-10-07T13:51Z 2769 followers, XXX engagements
"$ANAB +5.29% today as Anaptys Announces Late-Breaking Oral Presentation of Complete Phase 2b Data for Rosnilimab in Rheumatoid Arthritis at Upcoming ACR Convergence 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2769 followers, XXX engagements
"$OCUL Ocular Therapeutix announced they will present Phase X Wet Macular Degeneration results in 1Q26 for OTX-TKI More Info:"
X Link @OzmosiHealth 2025-10-01T20:37Z 2769 followers, XXX engagements
"$NBIX Neurocrine presented Phase X Depressive Disorder Major results on 2025-09-22 for Osavampator More Info:"
X Link @OzmosiHealth 2025-09-23T20:27Z 2769 followers, XXX engagements
"$KRYS +0.38% today as Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2768 followers, XXX engagements
"$NBIX -XXXX% today as Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA (valbenazine) Capsules for Huntington's Disease Chorea More Info:"
X Link @OzmosiHealth 2025-10-06T13:47Z 2769 followers, XXX engagements
"$SPRO +0.18% today as Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2768 followers, XX engagements
"$CERO -XXXX% today as CERo Therapeutics Announces Completion of First Cohort of Phase X Clinical Trial of CER-1236 in AML More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2768 followers, XXX engagements
"$SLS Sellas Life Sciences announced they will present Preclinical T-Cell Peripheral Lymphoma results on 2025-10-18 for Tambiciclib More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ACAD Acadia will present Preclinical Essential Tremor Data for SAN-711 (GABRA3 Modulator - Small Molecule) tomorrow 👀"
X Link @OzmosiHealth 2025-10-07T11:12Z 2770 followers, XXX engagements
"$BOLT +8.85% today as Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 More Info:"
X Link @OzmosiHealth 2025-10-01T20:37Z 2770 followers, XXX engagements
"$RGNX +3.55% today as REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD More Info:"
X Link @OzmosiHealth 2025-10-06T13:47Z 2769 followers, XXX engagements
"$SNY +0.10% today as Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase X study demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors More Info:"
X Link @OzmosiHealth 2025-10-08T13:46Z 2769 followers, XXX engagements
"$ALXO ALX Oncology announced they will present Phase X Esophageal CancerGastrointestinal Cancer results on 2025-11-08 for Evorpacept More Info:"
X Link @OzmosiHealth 2025-10-06T20:04Z 2770 followers, XXX engagements
"$NANO as NANOBIOTIX Announces First Data From Phase X Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer More Info:"
X Link @OzmosiHealth 2025-10-01T20:37Z 2769 followers, XXX engagements
"Pharma/Biotech Highlights: $MNKD: MannKind expands patent portfolio with Clofazimine. $PHAT: FDA approves Phathom's Vonoprazan tablets. $BMY: EMA approves Bristol Myers Squibb's Opdivo. $DCPH: Positive Phase X results for Vimseltinib"
X Link @OzmosiHealth 2023-10-30T20:35Z 2770 followers, XXX engagements
"$BMRN Biomarin presented Phase X Achondroplasia results on 2025-09-08 for Vosoritide More Info:"
X Link @OzmosiHealth 2025-09-09T20:18Z 2769 followers, XXX engagements
"$BCTX BriaCell announced they will present Phase X Breast Cancer results on 2025-10-20 for SV-BR-1-GM More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2769 followers, XX engagements
"$CRVO +5.07% today as CervoMed Announces New Data from Phase 2b Trial Demonstrating Neflamapimod's Potential as a Treatment for Dementia with Lewy Bodies More Info:"
X Link @OzmosiHealth 2025-10-08T13:46Z 2770 followers, XXX engagements
"$PMVP PMV Pharmaceuticals announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-24 for Rezatapopt More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"$LEGN Legend Biotech Appoints Carlos Santos as Chief Financial Officer"
X Link @OzmosiHealth 2025-08-18T20:45Z 2770 followers, XXX engagements
"$NTHI NeOnc Technologies receives $XXX million in NIH STTR grants for developing NEO212 in Gliomas and Leukemia. More Info: $XBI $IBB $XPH $PPH"
X Link @OzmosiHealth 2025-08-07T13:05Z 2770 followers, XXX engagements
"$ATXS Astria Therapeutics partners with Kaken Pharmaceutical to develop and sell Navenibart for HAE in Japan. More Info: $XBI $IBB $XPH $PPH"
X Link @OzmosiHealth 2025-08-06T12:34Z 2769 followers, XXX engagements
"$ABEO -XXXX% today as Abeona Therapeutics Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2770 followers, XXX engagements
"$FDMT -XXXX% today as 4DMT Advances 4D-710 to Phase X with Additional Funding and Support from the Cystic Fibrosis Foundation More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2769 followers, XXX engagements
"$PMVP -XXXX% today as PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase X Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2769 followers, XXX engagements
"$ARMP -XXXX% today as Armata Pharmaceuticals to Present Late-Breaking Clinical Data highlighting its Staphylococcus aureus Bacteriophage Cocktail AP-SA02 at IDWeek 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2768 followers, XX engagements
"$ZYME Zymeworks announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-23 for ZW-191 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"$BAYRY Bayer presented Phase X Muscular Dystrophies Limb-Girdle results on 2025-10-10 for LION-101 More Info:"
X Link @OzmosiHealth 2025-10-13T20:27Z 2769 followers, XXX engagements
"$UCBJY -XXXX% today as BIMZELX (bimekizumab-bkzx) New Three-year Data in Hidradenitis Suppurativa at EADV Showed Sustained Symptom Relief Across Multiple Clinical Endpoints More Info:"
X Link @OzmosiHealth 2025-09-17T14:07Z 2769 followers, XXX engagements
"$TNXP +2.49% today as Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb TNX-1500 at the 61st Annual Congress of the Japan Society for Transplantation More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$ALNY +0.05% today as Alnylam Announces First Patient Dosed in ZENITH Global Phase X Cardiovascular Outcomes Trial of Zilebesiran More Info:"
X Link @OzmosiHealth 2025-10-01T13:42Z 2768 followers, XXX engagements
"$GILD Gilead Sciences announced they will present Phase X Esophageal CancerGastrointestinal Cancer results on 2025-10-18 for Domvanalimab More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"$ATOS -XXXX% today as Atossa Advances Global Patent Strategy for Z-Endoxifen with New Protection in Israel and Ongoing Renewals More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2769 followers, XXX engagements
"Novo Nordisk is shutting down its cell therapy R&D unit as part of a major restructuring under new CEO Mike Doustdar"
X Link @OzmosiHealth 2025-10-13T13:26Z 2769 followers, XXX engagements
"$ABBV +0.46% today as U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ (upadacitinib) for the Treatment of Inflammatory Bowel Disease More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2770 followers, XXX engagements
"$EVAX Evaxion Biotech announced they will present Phase X Melanoma results on 2025-10-17 for EVX-01 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"$CORT Corcept announced they will present Phase X Ovarian Cancer results on 2025-10-19 for Relacorilant More Info:"
X Link @OzmosiHealth 2025-09-23T20:27Z 2770 followers, XXX engagements
"$ANL Adlai Nortye announced they will present Preclinical Oncology Solid Tumor Unspecified results on 2025-10-25 for AN-4035 More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2769 followers, XX engagements
"$CYTK PDUFA Summary: FDA extended action date for Aficamten NDA to December XX 2025. Stock price fell on disclosure. More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"$RNAZ +10.43% today as TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2768 followers, XXX engagements
"$CYTK Cytokinetics faced a setback when the U.S. FDA delayed approval for aficamten beyond the expected September XX 2025 PDUFA date. More Info:"
X Link @OzmosiHealth 2025-10-06T20:04Z 2767 followers, XXX engagements
"$BNR +1.06% today as Burning Rock's OncoGuide OncoScreen Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer More Info:"
X Link @OzmosiHealth 2025-09-24T13:53Z 2769 followers, XXX engagements
"$ONC +2.86% today as BeOne Medicines' Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2770 followers, XXX engagements
"$UCBJY Two-year data presented at AAD demonstrates efficacy of BIMZELX in eliminating draining tunnels in Hidradenitis Suppurativa and reducing disease burden. More Info: $XBI $IBB $XPH $PPH"
X Link @OzmosiHealth 2025-03-07T13:34Z 2769 followers, XXX engagements
"$VOR -XXXX% today as Telitacicept Demonstrates Clinically Meaningful and Statistically Significant Impact on ESSDAI Compared to Placebo in Late-Breaking China Phase X Results in Primary Sjgren's Disease at ACR 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2768 followers, XXX engagements
"$LYRA Lyra Therapeutics announced they will present Phase X Sinusitis results on 2025-10-13 for Mometasone furoate More Info:"
X Link @OzmosiHealth 2025-10-08T01:56Z 2770 followers, XXX engagements
"Daily $XBI Summary $ATYR +15% $MLYS +3% $CDTX +3% $NRIX -X% $BHVN -X% $SYRE -4%"
X Link @OzmosiHealth 2025-10-10T14:57Z 2769 followers, XXX engagements
"$BMY Bristol-Myers Squibb announced they will present Phase X Non-Small-Cell Lung Cancer results on 2025-10-17 for Izalontamab brengitecan More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2769 followers, XX engagements
"$RARE Ultragenyx presented Phase X Glycogen Storage Disease Type Ia results on 2025-09-08 for Pariglasgene brecaparvovec More Info:"
X Link @OzmosiHealth 2025-09-09T20:19Z 2770 followers, XXX engagements
"$PYXS Pyxis Oncology announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-18 for Micvotabart pelidotin More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"$TOVX Theriva Biologics announced they will present Phase X Pancreatic Cancer results on 2025-10-20 for Zabilugene almadenorepvec More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"$IMAB +1.64% today as I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2768 followers, XXX engagements
"$NUVL Nuvalent announced they will present Preclinical Oncology Solid Tumor Unspecified results on 2025-10-24 for NVL-330 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XX engagements
"$MRUS -XXXX% today as Merus Announces Publication of an Abstract on Petosemtamab in Metastatic Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$BIIB -XXXX% today as LEQEMBI (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Australia More Info:"
X Link @OzmosiHealth 2025-09-24T13:53Z 2770 followers, XXX engagements
"$GYRE -XXXX% today as Gyre Therapeutics to Present Results from Positive Phase X Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLDThe Liver Meeting 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2768 followers, XX engagements
"$BCAX +3.35% today as Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2770 followers, XXX engagements
"$SGMT -XXXX% today as Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XX engagements
"$ZLAB +3.61% today as Zai Lab Announces Oral Presentation of Updated Data from Global Phase X Trial of Zocilurtatug Pelitecan (ZL-1310) a Potential First-in-Class DLL3-Targeted ADC at 2025 AACR-NCI-EORTC Conference More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2769 followers, XXX engagements
"$NGNE +11.06% today as Neurogene Announces Positive Regulatory Update for NGN-401 Gene Therapy in Rett Syndrome with Plans to Initiate Dosing in Embolden Registrational Trial in Q4 2025 More Info:"
X Link @OzmosiHealth 2025-10-09T13:39Z 2770 followers, XXX engagements
"$TNG as Transgene and BioInvent to Present Translational Data and Updated Clinical Results on Armed Oncolytic Virus BT-001 at ESMO 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2768 followers, XXX engagements
"$GUD as Knight Therapeutics Announces Relaunch of ORGOVYX in Canada More Info:"
X Link @OzmosiHealth 2025-10-07T13:51Z 2769 followers, XXX engagements
"$ZNTL Zentalis Pharmaceuticals announced they will present Phase X Oncology Solid Tumor UnspecifiedGastrointestinal Cancer results on 2025-10-24 for Azenosertib More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2769 followers, XXX engagements
"$XNCR -XXXXX% today as Xencor Announces Presentation of Initial Phase X Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-14T21:37Z 2770 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $LYRA Lyra Therapeutics will present Phase X Sinusitis Data for Mometasone furoate (Corticosteroid Hormone Receptor Agonist - Small Molecule) tomorrow 👀"
X Link @OzmosiHealth 2025-10-12T11:12Z 2769 followers, XXX engagements
"$CORT +1.40% today as Corcept Submits Marketing Authorization Application to European Medicines Agency for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$KYMR +2.76% today as Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-621 a First-In-Class Oral STAT6 Degrader at the European Academy of Dermatology & Venereology and European Respiratory Society Congresses More Info:"
X Link @OzmosiHealth 2025-09-17T14:07Z 2769 followers, XXX engagements
"$JNJ Johnson & Johnson presented Phase X Depressive Disorder Major results on 2025-10-12 for Lumateperone More Info:"
X Link @OzmosiHealth 2025-10-13T20:27Z 2769 followers, XXX engagements
"US government shutdown prompts reductions in force (RIFs) at the Department of Health & Human Services"
X Link @OzmosiHealth 2025-10-13T13:26Z 2770 followers, XXX engagements
"$IMAB -XXXX% today as I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments More Info:"
X Link @OzmosiHealth 2025-09-08T13:43Z 2770 followers, XXX engagements
"$TSHA +0.89% today as Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting More Info:"
X Link @OzmosiHealth 2025-10-09T13:39Z 2768 followers, XXX engagements
"$AKRO Akero announced they will present Phase X Non-alcoholic Steatohepatitis results on 2025-11-09 for Efruxifermin More Info:"
X Link @OzmosiHealth 2025-10-08T20:06Z 2770 followers, XXX engagements
"$LXRX +1.39% today as Lexicon Pharmaceuticals Presents Additional Pilavapadin Data in Diabetic Peripheral Neuropathic Pain at 19th Annual Pain Therapeutics Summit More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"Regeneron is preparing an FDA submission for DB-OTO its gene therapy for profound genetic hearing loss following updated trial data"
X Link @OzmosiHealth 2025-10-13T13:26Z 2770 followers, XXX engagements
"$ZYME +0.42% today as Zymeworks to Present Clinical Data from the Phase X trial of ZW191 an Antibody-Drug Conjugate Targeting Folate Receptor- at AACR-NCI-EORTC International Conference More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2769 followers, XXX engagements
"$ANAB AnaptysBio announced they will present Phase X Arthritis Rheumatoid results on 2025-10-29 for Rosnilimab More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2769 followers, XXX engagements
"$DTIL -XXXX% today as Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$UCBJY UCB reports the publication of Phase X BIMZELX trials in The Lancet for moderate-to-severe Hidradenitis Suppurativa. More Info: $XBI $IBB $XPH $PPH"
X Link @OzmosiHealth 2024-05-23T14:02Z 2769 followers, XX engagements
"$CRBP +0.28% today as Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2769 followers, XXX engagements
"$CDTX Cidara announced they will present Phase X Influenza Human results on 2025-10-23 for CD-388 More Info:"
X Link @OzmosiHealth 2025-10-13T20:27Z 2769 followers, XXX engagements
"$TBPH +1.87% today as Theravance Biopharma to Present New Analyses Highlighting YUPELRI (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2768 followers, XX engagements
"$INCY +1.20% today as Incyte Announces New 24-Week Phase X Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 2025 More Info:"
X Link @OzmosiHealth 2025-09-17T14:07Z 2770 followers, XXX engagements
"$JAZZ +1.52% today as Jazz Pharmaceuticals Showcases Phase X Data Demonstrating Xywav (calcium magnesium potassium and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses More Info:"
X Link @OzmosiHealth 2025-09-22T21:16Z 2769 followers, XXX engagements